Desensitization of the nicotinic acetylcholine receptor by diisopropylfluorophosphate
β Scribed by Eldefrawi, Mohyee E. ;Schweizer, Gordon ;Bakry, Nabil M. ;Valdes, James J.
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 615 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0887-2082
No coin nor oath required. For personal study only.
β¦ Synopsis
The interaction of diisopropylfluorophosphate (DFP) with the nicotinic acetylcholine (ACh) receptor of Torpedo electric organ was studied, using [3H]-phencyclidine ([3H]-PCP) as a reporter probe. Phencyclidine binds with different kinetics to resting, activated, and desensitized receptor conformations. Although DFP did not inhibit binding of [3H]-ACh or 125I-alpha-bungarotoxin (BGT) to the receptor recognition sites and potentiated in a time-dependent manner [3H]-PCP binding to the receptor's high-affinity allosteric site, it inhibited the ACh- or carbamylcholine-stimulated [3H]-PCP binding. This suggested that DFP bound to a third kind of site on the receptor and affected receptor conformation. Preincubation of the membranes with DFP increased the receptor's affinity for carbamylcholine by eightfold and raised the pseudo-first-order rate of [3H]-PCP binding to that of an agonist-desensitized receptor. Accordingly, it is suggested that DFP induces receptor desensitization by binding to a site that is distinct from the recognition or high-affinity noncompetitive sites.
π SIMILAR VOLUMES
## Abstract The action of 5βhydroxytryptamine (5HT) on nicotinic acetylcholine receptor (nAChR) channels was investigated in mouse myotubes, human cloned TE671/RD cells, and __Xenopus laevis__ oocytes. The decay of the AChβactivated wholeβcell currents was reversibly accelerated in the presence of
results in an increased OD (Table 2). However, the presence of the resistant GGT allele can be directly determined using cPASA as previously described by Zhu and Clark. 7
Over the past few decades much effort has been expended elucidating the key domains of the nicotinic acetylcholine receptor (AChR) responsible for agonist binding, ion conduction, and gating. An emerging concept in the receptor field has been to consider the receptor entity as a signal transducer th
Since physostigmine (Phy) is presently used in the experimental treatment of Alzheimer disease (AD) patients by means of intracerebral ventricular (i.c.v.) administration, we designed a study to determine the effect of the drug administered by the same route on the cholinergic system of the rat brai